miONCO, a potential new blood test for 12 types of cancer developed as part of research at the University of Southampton funded by Against Breast Cancer, has been back in the news this week. In January, the University reported on how miONCO could change cancer diagnosis: Detecting cancer at an early stage is vital for improving …
Read moreJunior Research Fellow, Dr Lina Hacker has had a highly successful first year at Oriel College, University of Oxford. Dr Hacker is researching new ways to detect and investigate low oxygen levels (hypoxia) in breast cancer, a major source of treatment resistance and aggressiveness. Tumours often have low oxygen levels because they grow rapidly, outpacing …
Read more
When Against Breast Cancer launched ABC Discover in 2019, at the University of Southampton, our goal was to identify molecular biomarkers and diet and lifestyle factors that are associated with risk of secondary breast cancer. Using clinical information from 20,000 cancer patients, our research scientists have developed a new early cancer detection blood test called miONCO. …
Read more
Research from Dr Oliver Pearce, Dr Priyanka Hirani and their team at Barts Cancer Institute, have discovered that different forms of a protein called Versican can either block, or support, the entry of cancer-killing immune cells into tumours in triple-negative breast cancer (TNBC). TNBC is one of the most challenging types of breast cancer to …
Read more
In a joint study published between the University of Southampton’s Centre for Cancer Immunology and the School of Biological Sciences, a key aspect of the immune system has been put under scrutiny. It is known that many therapeutic antibodies targeting cancer work by recruiting the immune system. However, the body has a large amount of …
Read more